Clinical Updates

The U.S. Food and Drug Administration announced this week that it has approved a new tissue adhesive, Artiss, for… »   

The U.S. Food and Drug Administration (FDA) announced this week the approval of Cimzia (certolizumab pegol) for the treatment of… »   

The laser eye surgery industry is steeling itself ahead of a Friday meeting expected to draw complaints from patients with… »   

The U.S. Food and Drug Administration has warned Zila Pharmaceuticals Inc about promoting its Peridex oral rinse without including information… »   

U.S. health officials approved Belgian drugmaker UCB Inc’s experimental drug to treat Crohn’s disease but warned about serious side effects,… »   

Lax U.S. oversight of drug ingredient makers in China and other countries is putting Americans at risk of exposure… »   

An online advertisement with men praising Viagra to the tune of an Elvis Presley song has drawn objections from U.S.… »   

U.S. authorities increased inspections of foreign drug plants last year but still checked only a fraction of sites that supply… »   

Switzerland’s Novartis AG is cutting prices for its malaria drug Coartem by a fifth to improve access to treatment, especially… »   

For patients who underwent angioplasty to open narrowed coronary arteries, the use of stents releasing the drug everolimus reduced the… »   

Tuberculosis (TB) has long been one of the world’s great killers. Now, forms of drug-resistant TB—multidrug (MDR) and extensively drug-resistant… »   

Drug giant Merck has been caught red-handed in a scheme to deceive the FDA and the public over the integrity… »   

A cheaper, generic version of GlaxoSmithKline Plc’s Wellbutrin XL antidepressant is just as safe and effective, despite complaints from some… »   

The U.S. Food and Drug Administration has approved a combination migraine drug from GlaxoSmithKline Plc and Pozen Inc, the companies… »   

Biogen Idec and its partner Elan Corp said on Tuesday no new cases of a potentially deadly brain infection… »